global view constructed of white lines

Blog

January 3, 2023

PNI Scientists Explore Using Psychedelics to Treat Alcohol, Drug Disorders

by Guest Author

Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.

January 1, 2023

PNI Founders’ Message 2023

by Daniel F. Kelly

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

December 13, 2022

PNI Publishes First-Ever Paper on Psychedelics in Neurosurgery and Neuro-oncology Literature

by PNI Experts

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).

Depression
September 6, 2022

What is Ketamine Therapy?

by Keith Heinzerling

Ketamine is approved for use at high doses as an anesthetic in the operating room. Although not FDA-approved, lower dose “sub-anesthetic” ketamine injections are used “off-label” to treat depression, pain, and other mental health/substance use disorders.  In recent times, there have been many factors contributing...

220726 USNWR award
July 27, 2022

Neurology and Neurosurgery High Level Performance Recognized at Providence Hospitals

by Zara Jethani

Pacific Neuroscience Institute teams in Neurology and Neurosurgery contribute to High Performing Hospitals in US News & World Report rankings.

LA Mag top docs 2022
April 7, 2022

Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2022

by Zara Jethani

This year, six of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2022 roster of “L.A.’s Top Doctors.”

Pacific Brain Health Center Building
January 12, 2022

Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute

by Zara Jethani

Pacific Neuroscience Institute (PNI) located at Providence Saint John's Health Center, has activated a new psilocybin clinical trial and has begun participant enrollment.

January 1, 2022

PNI Founders’ Message 2022

by Daniel F. Kelly

At Pacific Neuroscience Institute, we are looking forward to what lies ahead with fresh excitement. Neurological diseases do not stop and neither have we.

Clinical trials at Pacific Neuroscience Institute
December 1, 2021

The Role of Clinical Trials at PNI

by Amelia Garrison

Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.

CME Integrating lifestyle strategies for neurologic disease
October 27, 2021

Integrating Lifestyle Strategies into the Care of Neurologic Disease – Brain Health CME Course

by Zara Jethani

Pacific Neuroscience Institute announces an exciting brain health CME course for practicing clinical professionals. Registration is open.

Last updated: November 19th, 2021